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In spite of the recent improvements in drug therapy, surgery still represents the most frequent treatment for Crohn’s disease (CD)
complications. Laparoscopy has been widely applied over the last twenty years in colorectal surgery and was associated with lower
postoperative pain, shorter hospitalization, faster return to daily activities, and better cosmetic results. Laparoscopy experienced a
slower diﬀusion in inflammatory bowel disease surgery than in oncologic colorectal surgery, but proved to be safe and eﬀective,
and is currently considered the gold standard for the treatment of primary uncomplicated ileocolic CD. Indications for laparoscopy
in CD have recently been widened to embrace more complicated or recurrent CD. This paper reviews the available data on the
subset of recurrent CD patients. The reported results indicate that laparoscopy may be safely applied even in selected recurrent CD
cases in hands of IBD surgeons with broad laparoscopic experience.
1. Introduction
Crohn’s disease (CD) is a chronic and idiopathic inflam-
mation that can aﬀect any part of the gastrointestinal tract.
The terminal ileum is the most frequently involved site,
and first diagnosis is generally made between the ages of
20 and 30 years. Surgery plays a very important role in
the management of CD. 70% to 90% [1] of diagnosed
patients eventually require surgery, usually for complications
or failure of medical treatment. Approximately 40% to 50%
of patients undergoing surgery are likely to need further
operations within 10–15 years [2].
Laparoscopic colorectal surgery began in the early 90s
and rapidly spread, gaining acceptance for diﬀerent indica-
tions, both benign and malignant.
The reduction of postoperative pain, commonly experi-
enced by laparoscopic patients, allows a faster mobilization
and improves pulmonary function [3]; these factors can con-
tribute to lower complications rates [4] and make patients’
recovery smoother.
Significantly faster resumption of bowel function, a
shorter hospital stay, and a lower overall morbidity are
included among the generally mentioned benefits of laparo-
scopic surgery [5–11]. It is well known that the use of opi-
ate analgesics negatively aﬀects recovery of gastrointestinal
function [12]. Laparoscopic approach, probably due to both
limited incision extension and bowel manipulation, reduces
postoperative pain and morphine administration and leads
to rapid resolution of paralytic ileus and discharge from
hospital, respectively. Such results were reported also for
inflammatory bowel diseases [13].
In particular, CD patients are potentially optimal can-
didates for laparoscopy because they are mostly young
and potentially more concerned about body image and
cosmetic results. The high risk of surgical recurrence is a
further reason to preserve the integrity of the abdominal
wall. Furthermore, laparoscopic surgery might induce less
adhesions [14], and since CD patients may undergo repeated
surgery during their lives, this means lower risk of surgery
for subocclusion. In case of need of subsequent surgery, the
resulting operation used to be much easier.
In recurrent CD, the diﬀusion of laparoscopy was limited
by objective technical diﬃculties and disease-related factors
as fragility of inflamed, thickened mesentery and loops,
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presence of inflammatory masses or abscesses, fistulas, and
massive adhesions.
Several studies, including four randomized trials [5,
6, 15, 16] and three meta-analyses [17–19], demonstrated
the benefits of laparoscopy for primary small bowel CD
regarding short-term outcomes such as postoperative pain,
use of medication, complication rates, return to normal
bowel habits, hospital stay, and cosmesis. For these rea-
sons, laparoscopy in primary CD is nowadays consid-
ered the first choice treatment in most referral surgical
centers.
The mean conversion rate reported in the current
literature is 11.2% and ranges from 4.8% to 29.2% [17].
The duration of surgery for laparoscopic ileocolic resection
can be very similar to open surgery after completion of the
learning curve by the surgical team [6, 20, 21].
The safety of laparoscopic ileocolectomy has been proven
also in the long-term outcomes by Eshuis and colleagues
[22].
Today, surgeons refined their laparoscopic technical skills
and got the help of new-generation instruments; indications
for CD surgery broadened from uncomplicated ileocaecal
resection or simple stoma formation to more complex
procedures, even for recurrent disease.
Another major improvement in colorectal surgery has
been represented by the introduction of a fast-track periop-
erative care program, also referred to as enhanced recovery
after surgery (ERAS) [23, 24], whichmay reduce hospital stay
to 2-3 days after open colorectal surgery [25, 26], even if high
readmission rates are reported [25, 27]. Only a few studies
evaluated the role of the laparoscopic approach combined
to fast-track protocols in enhancing recovery after colorectal
surgery and report conflicting results. Basse et al. [28]
found no diﬀerence between fast-track patients undergone
laparoscopic or open resection, while King et al. [29] found
a significant reduction of the hospital stay in fast-track
patients after laparoscopic surgery. The only randomized,
multicentric clinical trial (LAFA study) [30] that investigated
both surgical technique (laparoscopic and open) combined
with fast-track and standard care demonstrated that the best
option is laparoscopic resection embedded in a fast-track
care procedure. All studies on laparoscopy and enhanced
recovery protocols are focused on colon cancer and have
not been validated yet in patients with inflammatory bowel
disease, which may have a very diﬀerent immunologic
background.
The few literature reports on recurrent CD treated by
laparoscopy will be reviewed in the following section.
2. Recurrent Crohn’s Disease
In the current literature, there are a few studies investigating
the feasibility and safety of laparoscopic resection for recur-
rent disease [31].
Details on the published studies on the results of
laparoscopic surgery for recurrent CD are described in
Tables 1 and 2.
Wu et al. [32] compared the results of 46 consecu-
tive patients who underwent laparoscopic ileocolic resec-
tion for CD with a group of 70 patients treated by
conventional open surgery. Within the laparoscopic group,
there were 10 recurrent CD patients, 14 complicated CD
(abscess/phlegmon) patients, and 22 primary uncomplicated
ileocecal CD patients. Surgery in the open group was
significantly longer and intraoperative blood loss was higher
(both P < 0.05). Among the three laparoscopic groups,
return of bowel function was similar and shorter than in the
open group. Postoperative stay was significantly shorter for
laparoscopically treated patients (P < 0.01).
Hasegawa et al. [33] reported on 52 patients having
undergone 61 laparoscopic procedures for ileal or ileocolonic
CD. Sixteen procedures were performed for CD recurrence.
The first operation was in about half of the laparoscopic
cases. Operative time was significantly longer in the recur-
rence group (P = 0.012).
Moorthy et al. [34] in a series of 57 laparoscopic pro-
cedures included 26 laparoscopic operations for CD recur-
rence, comparing outcomes and conversion rates between
operation for primary and for recurrent CD. The conversion
rate was 42% (11/26) in the recurrent group and 13% (4/31)
in the primary group. The conversion rate was not influenced
by the approach (open versus laparoscopic) nor by the
type of previous surgery (resection, stoma, drainage, and
stricturoplasty). Patients submitted to laparoscopic surgery
for recurrent CD experienced a higher conversion rate, but
similar outcomes compared to primary CD.
Uchikoshi et al. [35] reported 43 operations for recurrent
CD. Surgery started laparoscopically in 23 patients, but 6
were intraoperatively converted to a hand-assisted procedure
and 10 to a conventional open surgery, so that in conclusion
only 7 patients completed the operation laparoscopically.
Lawes and Motson [36], in a short note, reported 15
laparoscopic procedures on 14 patients for recurrent CD
with no conversions. Surgical procedures were not limited
to ileocolic resection but included also stricturoplasty,
abdominoperineal resection, subtotal colectomy, and small
intestine resection. No diﬀerences were found in major com-
plication rates and length of stay among patients submitted
to surgery for primary or recurrent CD.
A recently published prospective study from Goyer et al.
[37] on 124 attempted ileocolonic resections for CD includes
54 patients with complex disease, defined as recurrent CD
after ileocolonic resection (27%) or by the presence of
fistula (43%) or abscess (30%). The complex/recurrent CD
group was associated with significantly longer operative
time (P < 0.05), higher conversion rate (P < 0.01), and
increased performance of temporary stomas (P < 0.001),
with no diﬀerence in postoperative outcome if compared
with noncomplicated CD group.
Chaudhray and colleagues [38] described a large series
of 59 laparoscopic ileocolic resections (30 for recurrent CD)
showing the same benefits observed after primary resection
without increased complication rates, delayed discharge, or
high conversion rate.
Holubar et al. [39] reported a series of 40 patients
undergoing laparoscopy for recurrent ileocolic CD. In 75%
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of the cases, the resection could be carried out without
conversion. Conversion rate was significantly higher than
the one reported for primary disease by the same group
(25% versus 6.6%; P < 0.01). The comparison was made
between the completed laparoscopic group (n = 30) and
the converted group (n = 10). The short-term benefits of
laparoscopy are reported also in this series of operations
for recurrent disease. Among converted patients (25%), the
assumption of soft diet (3 versus 4 days; P = 0.03) and the
length of hospital stay (4 versus 7 days; P = 0.002) were
significantly delayed.
Broquet et al. [40] in a recent paper compared two
groups treated by laparoscopy (29) or conventional surgery
(33 procedures in 28 patients) for ileocolonic resection for
recurrence of CD; some of these patients were previously
treated with open surgery. Conversion rate was high in
the laparoscopic group (31% of cases) and was mainly
due to intestinal injury, intraoperative discovery of fistula,
or diﬃcult intraperitoneal adhesions. In this experience,
even when converted, laparoscopy was not reported with
higher complication rate than the open group. In con-
clusion, Broquet et al. recommend laparoscopic approach
in selected patients with CD recurrence (previous laparo-
tomies <3, no previous history of peritonitis, nonfistulizing
disease).
Bandyopadhyay et al. [41] reported 27 patients treated by
laparoscopic ileocolic resection for recurrent CD. The short-
term outcome was analogue to the primary laparoscopic
ileocolonic resection.
Pinto et al. [42] compared the results of laparoscopic
surgery for primary (n = 80) and recurrent CD (n =
50), not limiting the indication to ileocolic resection, but
including also other procedures such as subtotal colectomies.
Surgical outcome was similar in both groups. The only
statistically significant diﬀerence was a longer incision in the
group of patients treated for recurrent CD. The incidence of
stoma formation was higher in converted cases, even if not
statistically significant.
3. Conclusions
Laparoscopic surgery represents a widely accepted option for
selected CD patients: a broad spectrum of procedures, from
simple to very complex, can be technically performed. The
main accepted indication remains today ileocecal resection
for primary uncomplicated CD.
In summary, even if evidence is lacking and more
contributions with larger sample size are needed, the limited
experiences available from the literature confirm that the
laparoscopic approach to recurrent CD should not be
avoided in principle; despite high technical diﬃculty, in
hands of IBD surgeons with a deep expertise in laparoscopic
surgery, it can be feasible, safe and lead to significant
advantages in the postoperative period.
Laparoscopy for recurrence will be more often propos-
able in the near future, due to the increasing number of
ileocecal resections already performed by laparoscopy for
primary CD.
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